North America Startup Funding Rounds
Startups raising capital across North America. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 2,314 Jan 1 – Oct 26, 2026
- Disclosed funding
- $254B 1919 disclosed amounts
- Median round
- $23.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
 MOSH makes protein bars marketed for brain health. | $13M | Series A | Foodtech | United States | Investors | |
| J JettyCompany profile Builds infrastructure for running, evaluating, and improving autonomous AI agents in production Builds infrastructure for running, evaluating, and improving autonomous AI agents in production | $2M | Pre-SeedPre-seed | AI | Canada | Investors | |
| KB Kanvas BiosciencesCompany profile Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy | $48M | Series A | Biotech | United States | Investors | |
| C Provides full-stack insurance platform for commercial insurance infrastructure | $160M | Series B | Fintech | United States | Investors | |
| D DistrictCompany profile AI commerce platform helping creators and brands build custom online storefronts without coding AI commerce platform helping creators and brands build custom online storefronts without coding | $14.7M | Seed | AI | United States | Investors | |
| S SaltboxCompany profile Co-warehousing and logistics operations hub for product-based businesses scaling across US markets Co-warehousing and logistics operations hub for product-based businesses scaling across US markets | Undisclosed | Series CSeries C+ | Ecommerce | United States | Investors | |
 LTZ TherapeuticsCompany profile LTZ Therapeutics develops cancer immunotherapies that target myeloid biology. LTZ Therapeutics develops cancer immunotherapies that target myeloid biology. | $38M | Undisclosed | Biotech | United States | Investors | |
| X XBOWCompany profile Runs autonomous AI agents that continuously probe software for vulnerabilities at machine speed Runs autonomous AI agents that continuously probe software for vulnerabilities at machine speed | $35M | Series C+ | Cybersecurity | United States | Investors | |
| GS Griffin Special Opportunities FundCompany profile Griffin Gaming Partners fund providing project financing to independent game developers through revenue-sharing agreements. Griffin Gaming Partners fund providing project financing to independent game developers through revenue-sharing agreements. | $100M | Special Opportunities Fund launchUndisclosed | Media & gaming | United States | Investors Undisclosed | |
| S Builds shared context infrastructure for AI-native teams | $15M | Seed | AI | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
134rounds3led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
99rounds20led - 3General Catalyst
Provision Labs, Tractian, Different
71rounds7led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
60rounds0led - 5Khosla Ventures
Arda Industries, Tolan
59rounds6led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.